Upcoming events on SAGE THERAPEUTICS, INC. |
|
02/25/21 | | FY 2020 Earnings Release (Projected) |
05/06/21 | | Q1 2021 Earnings Release (Projected) |
08/10/21 | | Interim 2021 Earnings Release (Projected) |
11/11/21 | | Q3 2021 Earnings Release (Projected) |
|
Past events on SAGE THERAPEUTICS, INC. |
|
01/12/21 | 10:50am | | JP Morgan Healthcare Conference |
12/09/20 | 03:00pm | | BMO Capital Markets Boston Growth Conference |
11/30/20 | 08:00am | | Biogen Inc and Sage Therapeutics, Inc Gobal Collaboration and License Agreement Call |
11/19/20 | 04:05pm | | Wolfe Virtual Healthcare Conference |
|
Upcoming sector events for SAGE THERAPEUTICS, INC. |
|
|
|
Past sector events for SAGE THERAPEUTICS, INC. |
|
|
|
Annual results | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 (e) |
Sales M $ |
Released Forecast Spread |
|
|
| 90,3 90,0 0,30% | 6,87 8,72 -21% | 7,04
|
Operating income (EBITDA) M $ |
Released Forecast Spread | -94,5 -93,3 -1,4% | -160 -140 -14% | -273 -285 4,4% | -392 -375 -4,5% | -706 -736 4,0% | -479
|
Operating profit (EBIT) M $ |
Released Forecast Spread | -94,7 -93,5 -1,3% | -160 -144 -11% | -273 -282 3,2% | -393 -369 -6,6% | -708 -728 2,8% | -483
|
Pre-Tax Profit (EBT) M $ |
Released Forecast Spread | -94,5 -94,0 -0,56% | -159 -144 -10% | -270 -279 3,0% | -373 -347 -7,4% | -680 -701 2,9% | -471
|
Net income M $ |
Released Forecast Spread | -94,5 -93,4 -1,2% | -159 -144 -10% | -270 -279 3,3% | -373 -349 -6,8% | -680 -700 2,9% | -473
|
EPS $ |
Released Forecast Spread | -3,40 -3,35 -1,6% | -4,75 -4,38 -8,4% | -7,09 -7,38 3,9% | -8,08 -7,54 -7,1% | -13,4 -13,8 2,7% | -9,07
| Announcement Date | 02/24/2016 | 02/23/2017 | 02/22/2018 | 02/19/2019 | 02/27/2020 | |
|
|
Quarterly results | 2018 Q2 | 2018 Q3 | 2018 Q4 | 2019 Q1 | 2019 Q2 | 2019 Q3 | 2019 Q4 | 2020 Q1 | 2020 Q2 | 2020 Q3 | 2020 Q4 (e) | 2021 Q1 (e) | 2021 Q2 (e) | 2021 Q3 (e) | 2021 Q4 (e) |
Sales M $ |
Released Forecast Spread | 90,0
|
| 0,27
| 0,47
| 0,87 0,27 223% | 3,57 2,52 41% | 1,96 3,76 -48% | 2,30 2,81 -18% | 1,09 0,88 24% | 1,64 1,85 -11% | 10,1
| 161
| 18,5
| 29,1
| 21,5
|
Operating income (EBITDA) M $ |
Released Forecast Spread | -21,9 -94,8 77% | -128 -125 -2,9% | -164 -145 -13% | -169 -170 0,35% | -176 -178 0,94% | -186 -183 -1,8% | -174 -204 15% | -131 -178 26% | -110 -141 22% | -107 -137 22% | -113
| 360
| -80,1
| -85,5
| -88,5
|
Operating profit (EBIT) M $ |
Released Forecast Spread | -22,1 -88,4 75% | -129 -116 -11% | -164 -141 -16% | -170 -161 -5,3% | -176 -175 -1,0% | -187 -182 -2,6% | -175 -194 10% | -132 -171 23% | -111 -141 22% | -108 -127 15% | -48,5
| 4,62
| -78,3
| -69,5
| -84,3
|
Pre-Tax Profit (EBT) M $ |
Released Forecast Spread | -17,0 -86,6 80% | -123 -112 -9,8% | -158 -136 -16% | -163 -154 -5,8% | -168 -169 0,46% | -180 -176 -2,1% | -169 -189 11% | -127 -167 24% | -136 -143 4,9% | -106 -127 17% | -30,8
| 35,7
| -72,0
| -60,4
| -77,9
|
Net income M $ |
Released Forecast Spread | -17,0 -87,1 81% | -123 -113 -8,6% | -158 -138 -15% | -163 -156 -4,6% | -168 -169 0,71% | -180 -176 -2,1% | -169 -188 10% | -127 -166 24% | -136 -140 2,6% | -106 -125 15% | -115
| -77,7
| -73,2
| -63,3
| -79,1
|
EPS $ |
Released Forecast Spread | -0,36 -1,91 81% | -2,63 -2,42 -8,6% | -3,38 -2,94 -15% | -3,37 -3,26 -3,5% | -3,28 -3,38 3,0% | -3,48 -3,41 -2,1% | -3,25 -3,62 10% | -2,44 -3,19 24% | -2,63 -2,69 2,3% | -2,03 -2,37 14% | -1,05
| 0,13
| -1,29
| -1,15
| -1,37
| Announcement Date | 08/07/2018 | 11/06/2018 | 02/19/2019 | 05/02/2019 | 08/06/2019 | 11/12/2019 | 02/27/2020 | 05/07/2020 | 08/10/2020 | 11/05/2020 | | | | | |
|
Financial data source © 2021 S&P Global Market Intelligence
|
|
© 2021 Factset
|
|
|
Net sales (Year) - Rate of surprise
EPS (Year) - Rate of surprise
Net sales (Quarter) - Rate of surprise
EPS (Quarter) - Rate of surprise
|